Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
| Curex BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth not weight loss
Set calendar reminders to check your statements around your billing date
Tirzepatide is FDA-approved and marketed as Mounjaro for type 2 diabetes and Zepbound for chronic weight management, backed by a large phase 3 program with multi-year follow-up
The peptide has demonstrated stability in gastric acid environments, which is relevant to oral bioavailability research, though the primary route studied in published multi-peptide protocols involves parenteral application in animal models [3]
Do not wait until deficiency develops
US$ 23.45
US$ 29.84
US$ 27.54
US$ 27.02
